Cervical Carious Lesions Restored With Calcium Silicate Based Cement (Biodentine) Compared With Glass-ionomer Cement
Gingival Health Around Cervical Carious Lesions Restored With Calcium Silicate Based Cement (Biodentine) Compared With Glass-ionomer Cement: A Randomized Clinical Trial
1 other identifier
interventional
28
0 countries
N/A
Brief Summary
This study will test if applying calcium silicate cements (Biodentine) to restore cervical carious lesions might adversely affect the gingival health in comparison with conventionally used tooth colored material (GIC)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2015
CompletedFirst Submitted
Initial submission to the registry
January 6, 2018
CompletedFirst Posted
Study publicly available on registry
February 1, 2018
CompletedFebruary 1, 2018
January 1, 2018
6 months
January 6, 2018
January 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in Gingival index around Cervical Carious Lesions Restored with Calcium Silicate Based Cement (Biodentine™) Compared with Glass-Ionomer Cement;
Gingival health will be measured using the Loe -Silness gingival scoring Index (1963) which scores gingivitis on a numerical scale according to the following criteria: * 0 = Absence of inflammation. * 1 = Mild inflammation, slight change in color, slight edema, no bleeding on probing. * 2 = Moderate inflammation, moderate glazing, redness, bleeding on probing. * 3- Severe inflammation, marked redness and hypertrophy, ulceration, tendency to spontaneous * Gingival index will be evaluated at four sites (mesial, distal, buccal, and lingual) on each tooth
6 months
Changes in Plaque accumulation around Cervical Carious Lesions Restored with Calcium
detect plaque level around restorations Plaque index (PI) (Silness and Löe, 1964). Plaque levels was measured using the Plaque Index Silness and Loe in 1964 Score Criteria 0 No plaque 1. A film of plaque adhering to the free gingival margin and adjacent area of the tooth, which cannot be seen with the naked eye. But only by Using disclosing solution or by using probe. 2. Moderate accumulation of deposits within the gingival pocket, on the gingival margin and/ or adjacent tooth surface, which can be seen with the naked eye. 3. Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin. Plaque index will be evaluated at four sites (mesial, distal, buccal, and lingual) on each tooth
6 months
Secondary Outcomes (1)
Changes in Pocket Depth around Cervical Carious Lesions Restored with Calcium
6 months
Study Arms (2)
GIC filling
SHAM COMPARATORIntervention/treatment One group will be treated with a tooth colored filling that will be placed near the gum line (Glass Ionomer). Placebo Comparator: GIC Participants will have a restoration placed with GIC in the lesion near the gum line. Device: GIC Application of a tooth colored filling in the cavitated dental lesion. Other Name: Resin modified glass ionomer
Biodentine filling
EXPERIMENTALIntervention/treatment The second group will be treated with Biodentine that will be placed near the gum line.Experimental: Biodentine Participants will have a restoration placed with Biodentine in the lesion near the gum line. Device: Biodentine Application of a white colored filling in dental lesion.
Interventions
Eligibility Criteria
You may qualify if:
- good general health;
- good oral hygiene; and
- age range 18-60 years old.
- Patients with the following criteria were excluded:
- current smokers;
- pregnant females;
- or patient with periodontal diseases; and
- those who had a history of poorly controlled diabetes, liver disease, malignancy, radiotherapy.
You may not qualify if:
- Pregnant women
- Patients taking benzodiazepines, narcotics and multiple antidepressants for pain management not associated with the oral cavity
- Patients requiring treatment for more than 5 decayed sites, periodontal disease and root canal therapy
- Complicated medical history (\>4 concurrent treatment for systemic diseases)
- Lesion \>1mm below the gum line
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rola Al Habashneh, ABP
JUST
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Investigator and participants are blinded to restoration used.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
January 6, 2018
First Posted
February 1, 2018
Study Start
January 3, 2015
Primary Completion
June 30, 2015
Study Completion
December 28, 2015
Last Updated
February 1, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share